Implementing the use of nomograms by choosing threshold points in predictive models: 2012 updated Partin Tables vs a European predictive nomogram for organ-confined disease in prostate cancer

被引:19
作者
Borque, Angel [1 ]
Rubio-Briones, Jose [2 ]
Esteban, Luis M. [3 ]
Sanz, Gerardo [4 ]
Dominguez-Escrig, Jose [2 ]
Ramirez-Backhaus, Miguel [2 ]
Calatrava, Ana [5 ]
Solsona, Eduardo [2 ]
机构
[1] Hosp Univ Miguel Servet, Dept Urol, Zaragoza, Spain
[2] Inst Valenciano Oncol, Dept Urol, Valencia, Spain
[3] Univ Zaragoza, Escuela Univ Politecn Almunia, E-50009 Zaragoza, Spain
[4] Univ Zaragoza, Dept Metodos Estadist, Zaragoza, Spain
[5] Inst Valenciano Oncol, Dept Pathol, Valencia, Spain
关键词
prostate cancer; nomograms; organ-confined disease; validation; thresholds; RADICAL PROSTATECTOMY; PATHOLOGICAL STAGE; CLINICAL STAGE; GLEASON SCORE; BIOCHEMICAL RECURRENCE; ROGERS; WILL PHENOMENON; 10-YEAR PROBABILITY; ANTIGEN; CURVE; MEN;
D O I
10.1111/bju.12532
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives To implement the use of nomograms in clinical practice showing how to choose thresholds in nomograms' predictions to select risk groups. To validate and compare the predictive ability and clinical utility of the Hospital Universitario Miguel Servet' (HUMS) and the updated Partin Tables 2012 (PT-2012) nomograms to predict organ-confined disease (OCD) after radical prostatectomy (RP). Patients and Methods Cohort of 1285 patients with prostate cancer treated with RP at Instituto Valenciano de Oncologia (IVO) between 1986 and 2011. The predictive value of the nomograms was assessed by means of calibration curves, discrimination ability (area under the receiver operating characteristic (ROC) curve (AUC) and probability density functions). The clinical utility was evaluated through Vickers' decision curves and thresholds were chosen through probability density functions. Results The calibration curves showed a minimal underestimation in low probabilities (<20%), a minimal overestimation in high probabilities (>50%) in the HUMS nomogram and a regular minimal overestimation in the PT-2012. Their AUC of 0.7285 (95% confidence interval [CI] 0.7010-0.7559) and 0.7288 (95%CI 0.7013-0.7562) respectively, show an adequate discrimination ability for both predictive models in the IVO cohort. The decision curves show similar net benefits for both models. In this study we advocate for a threshold of 53% for the identification of OCD. Conclusions The HUMS-nomogram and the PT-2012 predictions of OCD confirm their utility in a contemporary cohort of patients. Patients with a probability of OCD >53% should be classified as OCD, helping physicians to better counsel their patients. A selection of adequate thresholds, as presented in this paper, makes nomograms more accessible tools.
引用
收藏
页码:878 / 886
页数:9
相关论文
共 24 条
  • [1] Prostate cancer and the Will Rogers phenomenon
    Albertsen, PC
    Hanley, JA
    Barrows, GH
    Penson, DF
    Kowalczyk, PDH
    Sanders, MM
    Fine, J
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (17) : 1248 - 1253
  • [2] [Anonymous], 1998, DENSITY ESTIMATION S, DOI DOI 10.1201/9781315140919
  • [3] The use of neural networks and logistic regression analysis for predicting pathological stage in men undergoing radical prostatectomy: A population based study
    Borque, A
    Sanz, G
    Allepuz, C
    Plaza, L
    Gil, P
    Rioja, LA
    [J]. JOURNAL OF UROLOGY, 2001, 166 (05) : 1672 - 1678
  • [4] Borque A, 2006, ARCH ESP UROL, V59, P989
  • [5] Genetic predisposition to early recurrence in clinically localized prostate cancer
    Borque, Angel
    del Amo, Jokin
    Esteban, Luis M.
    Ars, Elisabet
    Hernandez, Carlos
    Planas, Jacques
    Arruza, Antonio
    Llarena, Roberto
    Palou, Joan
    Herranz, Felipe
    Raventos, Carles X.
    Tejedor, Diego
    Artieda, Marta
    Simon, Laureano
    Martinez, Antonio
    Carceller, Elena
    Suarez, Miguel
    Allue, Marta
    Sanz, Gerardo
    Morote, Juan
    [J]. BJU INTERNATIONAL, 2013, 111 (04) : 549 - 558
  • [6] Borque Angel, 2002, European Urology Supplements, V1, P67, DOI 10.1016/S1569-9056(02)80254-8
  • [7] Fernando AB, 2012, ARCH ESP UROL, V65, P39
  • [8] The University of California, San Francisco cancer of the prostate risk assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy
    Cooperberg, MR
    Pasta, DJ
    Elkin, EP
    Litwin, MS
    Latini, DM
    DuChane, J
    Carroll, PR
    [J]. JOURNAL OF UROLOGY, 2005, 173 (06) : 1938 - 1942
  • [9] An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011
    Eifler, John B.
    Feng, Zhaoyang
    Lin, Brian M.
    Partin, Michael T.
    Humphreys, Elizabeth B.
    Han, Misop
    Epstein, Jonathan I.
    Walsh, Patrick C.
    Trock, Bruce J.
    Partin, Alan W.
    [J]. BJU INTERNATIONAL, 2013, 111 (01) : 22 - 29
  • [10] The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
    Epstein, JI
    Allsbrook, WC
    Amin, MB
    Egevad, LL
    Bastacky, S
    Beltrán, AL
    Berner, A
    Billis, A
    Boccon-Gibod, L
    Cheng, L
    Civantos, F
    Cohen, C
    Cohen, MB
    Datta, M
    Davis, C
    Delahunt, B
    Delprado, W
    Eble, JN
    Foster, CS
    Furusato, M
    Gaudin, PB
    Grignon, DJ
    Humphrey, PA
    Iczkowski, KA
    Jones, EC
    Lucia, S
    McCue, PA
    Nazeer, T
    Oliva, E
    Pan, CC
    Pizov, G
    Reuter, V
    Samaratunga, H
    Sebo, T
    Sesterhenn, I
    Shevchuk, M
    Srigley, JR
    Suzigan, S
    Takahashi, H
    Tamboli, P
    Tan, PH
    Têtu, B
    Tickoo, S
    Tomaszewski, JE
    Troncoso, P
    Tsuzuki, T
    True, LD
    van der Kwast, T
    Wheeler, TM
    Wojno, KJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) : 1228 - 1242